AbCellera Biologics Initiated at Overweight by JP Morgan
Ratings actions from Benzinga: GMT) AbCellera Biologics Price Target Announced at $17.00/Share by JP MorganRatings actions from Benzinga
Ratings actions from Benzinga: GMT) AbCellera Biologics Price Target Announced at $17.00/Share by JP MorganRatings actions from Benzinga